Papers
8
Total Citations
162
H-Index
6
About
Marco Campetella is a pioneering urologic surgeon whose research centers on advancing robotic surgery, particularly for prostate cancer treatment. His major contributions involve the clinical validation and systematic evaluation of the novel Hugo™ RAS robotic platform, a next-generation system developed by Medtronic. Campetella has been instrumental in describing the system’s docking settings and surgical approach for robot-assisted radical prostatectomy (RARP), with his foundational 2022 paper accumulating 68 citations. He has led comprehensive meta-analyses and pooled analyses comparing the Hugo™ RAS to the established da Vinci system, demonstrating comparable surgical, oncological, and functional outcomes across large patient series—including a landmark study of 132 cases at a tertiary referral center. Beyond platform-specific work, Campetella investigates surgeon fatigue in minimally invasive surgery and explores quality-of-life outcomes, including post-prostatectomy urinary incontinence, sexual function, and dyadic adjustment. His systematic review on female sexual function after radical treatment for muscle-invasive bladder cancer highlights his commitment to patient-centered care. With over 160 citations across his most-cited works, Campetella is shaping the future of robotic urology by rigorously evaluating emerging technologies and their real-world impact on patients and surgeons alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8